MENU
NSTM
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

NovelStem International (NSTM) Ownership - Who owns NovelStem International?

NovelStem International Corp focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy... Show more

Profile

Industry
N/A
Address
2255 Glades Road
Phone
+1 410 654-3315
Employees
15
Web
https://www.novelstem.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
10.63M
P/E Ratio
N/A
Total Cash
40.56K
Projected Growth
N/A
Total Debt
357.53K
Revenue
12K
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

NSTM
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
2255 Glades Road
Phone
+1 410 654-3315
Employees
15
Web
https://www.novelstem.com